Abstract: The present invention provides a method for treating an individual who is afflicted with a cancer, such as non-small cell lung cancer or prostate cancer, by administering to that individual a MUC-1 based formulation. The formulation may be a MUC-1 based liposomal vaccine formulation.

Abstract: The present invention provides a method for treating an individual who is afflicted with a cancer, such as non-small cell lung cancer or prostate cancer, by administering to that individual a MUC-1-based formulation. The formulation may be a MUC-1 based liposomal vaccine formulation.

Abstract: The present invention provides a method for treating an individual who is afflicted with a cancer, such as non-small cell lung cancer or prostate cancer, by administering to that individual a MUC-1 based formulation. The formulation may be a MUC-1 based liposomal vaccine formulation.

Abstract: The present invention provides a method for treating an individual who is afflicted with a cancer, such as non-small cell lung cancer or prostate cancer, by administering to that individual a MUC-1-based formulation. The formulation may be a MUC-1 based liposomal vaccine formulation.

Abstract: The present invention provides a method for treating an individual who is afflicted with a cancer, such as non-small cell lung cancer or prostate cancer, by administering to that individual a MUC-1-based formulation. The formulation may be a MUC-1 based liposomal vaccine formulation.

Abstract: The present invention provides a method for treating an individual who is afflicted with a cancer, such as non-small cell lung cancer or prostate cancer, by administering to that individual a MUC-1-based formulation. The formulation may be a MUC-1 based liposomal vaccine formulation.

Abstract: The present invention provides liposomal vaccines containing immunogenic lipopeptides that are capable of modulating the humoral and cellular immune responses in vivo.

Abstract: The present invention provides liposomal vaccines containing immunogenic lipopeptides that are capable of modulating the humoral and cellular immune responses in vivo.

Abstract: The present invention provides liposomal vaccines containing immunogenic lipopeptides that are capable of modulating the humoral and cellular immune responses in vivo.

Abstract: The stroller includes a frame having at least one front leg, at least one rear leg, and at least one wheel mounted on each leg. The frame defines front and rear portions and right and left sides. The stroller also includes a seat having a seat base and a seat back pivotally mounted to the frame. The seat back has a front surface, a rear surface, a top portion and a bottom portion and is rotatable relative to the frame between at least one substantially upright or reclined back support position and a travel seat support position wherein the top portion of the seat back extends towards the front portion of the frame and is capable of supporting a travel seat thereon.

Abstract: The present invention provides liposomal vaccines containing immunogenic lipopeptides that are capable of modulating the humoral and cellular immune responses in vivo.

Abstract: The stroller includes a frame having at least one front leg, at least one rear leg, and at least one wheel mounted on each leg. The frame defines front and rear portions and right and left sides. The stroller also includes a seat having a seat base and a seat back pivotally mounted to the frame. The seat back has a front surface, a rear surface, a top portion and a bottom portion and is rotatable relative to the frame between at least one substantially upright or reclined back support position and a travel seat support position wherein the top portion of the seat back extends towards the front portion of the frame and is capable of supporting a travel seat thereon.

Abstract: A stroller having a frame with front and rear portions and right and left sides. A seat having a seat base and a seat back is mounted to the front portion of the frame. The seat back is rotatable relative to the frame between a back support position and a travel seat support position where the seat back is substantially parallel to and above the seat base when the stroller is in an operating position.

Abstract: New synthetic Lipid-A analogs based on monosaccharide (1) and disaccharide (2) derivatives were designed and prepared in the present invention. Both structures (1) and (2) incorporate novel lipid structures (3) and (4) that are not found in nature. Also, novel disaccharide Lipid-A structures (2) that incorporate novel contingents of uniform lipids and where R1, R4 and R5 are the same substitution group of structure (III) were synthesized. Liposome formulations containing totally synthetic components such as synthetic Lipid-A and synthetic lipopeptide derived from tumor-associated MUC1 mucin are described along with their therapeutic utility. Comparative test results of immunostimulating properties and toxicity of Lipid-A analogs (1) and (2) are included.

Abstract: The present invention provides a method for treating an individual who is afflicted with a cancer, such as non-small cell lung cancer or prostate cancer, by administering to that individual a MUC-1 based formulation. The formulation may be a MUC-1 based liposomal vaccine formulation.

Abstract: A high chair features various modes of adjustability and enhanced utility. The height of the chair can be adjusted using a single hand that engages a rear handle. The height of a seat platform of the chair can be adjusted separately relative to the tray. The tray itself is ergonomically designed for the benefit of the caregiver. A removable tray liner facilitates after-meal clean-up. Wheels on the underside of the tray ease fore/aft adjustment. A pivoting back rest of the chair minimizes rearward shift of the center of gravity of the occupied chair, thus requiring a smaller chair footprint. Further, an accessory bar pivoted to a seat back portion of the chair provides readily accessible entertainment.

Abstract: A high chair features various modes of adjustability and enhanced utility. The height of the chair can be adjusted using a single hand that engages a rear handle. The height of a seat platform of the chair can be adjusted separately relative to the tray. The tray itself is ergonomically designed for the benefit of the caregiver. A removable tray liner facilitates after-meal clean-up. Wheels on the underside of the tray ease fore/aft adjustment. A pivoting back rest of the chair minimizes rearward shift of the center of gravity of the occupied chair, thus requiring a smaller chair footprint. Further, an accessory bar pivoted to a seat back portion of the chair provides readily accessible entertainment.

Abstract: A high chair features various modes of adjustability and enhanced utility. The height of the chair can be adjusted using a single hand that engages a rear handle. The height of a seat platform of the chair can be adjusted separately relative to the tray. The tray itself is ergonomically designed for the benefit of the caregiver. A removable tray liner facilitates after-meal clean-up. Wheels on the underside of the tray ease fore/aft adjustment. A pivoting back rest of the chair minimizes rearward shift of the center of gravity of the occupied chair, thus requiring a smaller chair footprint. Further, an accessory bar pivoted to a seat back portion of the chair provides readily accessible entertainment.

Abstract: A high chair features various modes of adjustability and enhanced utility. The height of the chair can be adjusted using a single hand that engages a rear handle. The height of a seat platform of the chair can be adjusted separately relative to the tray. The tray itself is ergonomically designed for the benefit of the caregiver. A removable tray liner facilitates after-meal clean-up. Wheels on the underside of the tray ease fore/aft adjustment. A pivoting back rest of the chair minimizes rearward shift of the center of gravity of the occupied chair, thus requiring a smaller chair footprint. Further, an accessory bar pivoted to a seat back portion of the chair provides readily accessible entertainment.

Abstract: An infant travel system which include an infant travel seat that is adapted to be mounted to a stationary or mobile base. The base includes a restraint system for securing the base to a vehicle seat and a leveling system for positioning the base. The travel seat includes an adjustable carrying handle assembly having a locking mechanism adapted to engage the seat in a variety of positions. A multi-point locking system is used to secure the infant travel seat to the complimentary base.